C
CONTEXT THERAPEUTICS INC
NASDAQ: CNTX (Context Therapeutics Inc.)
最近更新时间: 2天之前, 5:09PM0.660
0.01 (1.37%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Context Therapeutics Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -1.0 |
| 平均 | 1.13 |
|
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 2.33% |
| 机构持股比例 | 79.93% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Mpm Bioimpact Llc | 31 Mar 2025 | 14,705,882 |
| Avidity Partners Management Lp | 31 Mar 2025 | 7,477,200 |
| Blue Owl Capital Holdings Lp | 31 Mar 2025 | 7,367,906 |
| Great Point Partners I Lp | 31 Mar 2025 | 4,683,711 |
| Ally Bridge Group (Ny) Llc | 31 Mar 2025 | 1,157,448 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 9.00 (D. Boral Capital, 1,263.22%) | 购买 |
| 中 | 6.50 (884.55%) | |
| 低 | 4.00 (Piper Sandler, 505.88%) | 购买 |
| 平均值 | 6.50 (884.55%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 0.712 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 26 Jun 2025 | 4.00 (505.88%) | 购买 | 0.651 |
| D. Boral Capital | 08 May 2025 | 9.00 (1,263.22%) | 购买 | 0.773 |
| 29 Apr 2025 | 9.00 (1,263.22%) | 购买 | 0.881 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合